Therapeutic Insights Services

Powered by CyTOF Technology

COVID-19 Grant Program for High-Dimensional Single-Cell Research

Fluidigm Therapeutic Insights Services is excited to launch the COVID-19 Research Grant Program (applicable in the US and Canada only) to support research and applications for the monitoring of human immune system response to COVID-19 disease with the unique Fluidigm high-multiplex tissue imaging technology, Imaging Mass Cytometry (IMC).

IMC enables the spatial visualization and single-cell analysis of immune response in tissue samples. Further, the high dimensionality of IMC allows for deeper insights into clinical outcomes and changes in inflammatory or immune function.

View our Terms and Conditions.

Apply Now

See the Impact of High-Dimensional Phenotyping

Revolutionize your translational or clinical research today with the insights that come from high-dimensional phenotyping. Fluidigm Therapeutic Insights Services make it easy to leverage mass cytometry and Imaging Mass Cytometry™ (IMC™) technologies for your research.

“Working with the Therapeutic Insights Services (TIS) team significantly enhanced the quality and rigor of our deep dive into the tumor microenvironment. TIS’s attention to detail and clear methodology greatly contributed to our study’s success.”

—Won Jin Ho, MD
Medical Oncology Fellow, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine


“The Hyperion Imaging System is a remarkable technology that enables translational researchers to quickly and deeply interrogate the tumor immune microenvironment using clinical biospecimens."

—Mark Yarchoan, MD
Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine

Highlights

Trust—Expert support for every step, to professionally manage your project.

Quality—Proven CyTOF technology for consistent and superior results from any sample type.

Transparency—Direct communication of planning, methods and analysis to meet every need.



Three simple steps to high-dimensional insights

Proven CyTOF technology used for mass cytometry and IMC services

CyTOF® technology is the foundation of the mass cytometry and Imaging Mass Cytometry single-cell analysis services performed using the Helios™ and Hyperion™ Imaging System platforms. The technology uses highly pure metal-tagged antibodies to resolve highly multiplexed protein markers and reveal systems-level biology at single-cell resolution. In contrast to approaches that utilize fluorescent tags, the metal-tag signals are separated by mass instead of by wavelength. This eliminates spectral overlap and tissue autofluorescence issues, significantly simplifies high-multiplex panel design and results in uniform staining with minimal background for top-quality data.

Sample-to-answer with mass cytometry and IMC services



Flexible service offering

Get started today on anything from a pilot study to a large-scale project. Our expert consultants will work with you to tailor a project to your disease of interest and the samples you want analyzed (Figure 1). Offering mass cytometry and Imaging Mass Cytometry services along with custom conjugation services, our experts will help you develop the best plan and then execute it to ensure that you get the most out of your precious samples.

Customized data analysis

Choose your preference of data analysis from a range of selections.

  • For mass cytometry: Staining quality assessment, viable cell selection and enumeration, 2D dot plots, t-SNE maps and summary report
  • Maxpar® Direct™ Immune Profiling Assay services are available to profile 37 immune cell populations from PBMC or whole blood and perform data processing using Maxpar Pathsetter™ software and include a full Maxpar Pathsetter analytic report.
  • For IMC: Image pre-processing, image segmentation, cell enumeration, phenotype characterization and summary report

Get more information

Yes! Sign me up to get more information about Fluidigm Therapeutic Insights Services.

Sign Up Now



Single-cell data analytics from a novel segmentation approach

Effective cell segmentation is important to generating quantitative results and more accurate data analysis. The Therapeutic Insights Services team has developed, and can use in your project, a custom multimarker panel that helps generate single-cell segmentation for better analysis that can drive more insights (Figure 2).

Technologies Used in Therapeutic Insights Services

Best-in-class Maxpar reagents

Therapeutic Insights Services uses Maxpar reagents and protocols to interrogate cells in tissue samples with IMC. Maxpar metal-conjugated antibodies can be chosen from our catalog or can be custom-conjugated by the Fluidigm services team as part of your service package. All Maxpar metal-conjugated catalog antibodies used in IMC have been evaluated by an independent pathologist for staining in appropriate tissue to ensure optimal results.

We are happy to consult and make a recommendation on the best antibody labeling approach if you already have a selection of unlabeled antibodies that you would like to use. Please ask us if you would like to have Fluidigm perform the staining on your samples of cells in solution, and we can discuss options for this.

Learn more about Maxpar antibodies and assays.

Unrivaled cell suspension analysis using mass cytometry

Enumerate cell populations and unveil new cell types, functions, signaling pathways and biomarkers using Helios for mass cytometry services. Our team will help you select from the more than 50 cell surface and intracellular markers that can be simultaneously interrogated in immunology, cancer, stem cells and more.

Services utilizing the Maxpar Direct Immune Profiling Assay and the accompanying Pathsetter analytical assessment are also available. We invite you to discuss your specific mass cytometry project requirements, including if you prefer to send unstained samples, with your Therapeutic Insights Services consultant.

Learn more about mass cytometry.

Spatially resolve proteins of interest with Imaging Mass Cytometry

Gain insights into the tissue microenvironment, developmental biology, disease progression or therapeutic response with services that utilize the Hyperion Imaging System for IMC. Our team can design a panel of up to 37 protein markers to include in a single-stain, single-scan multiplexed run. IMC provides unprecedented visualization of complex cellular phenotypes and their relationships in tissue microenvironments in the context of cancer, immuno-oncology, immune-mediated diseases and more.

Learn more about Imaging Mass Cytometry.

Learn more about Therapeutic Insights Services.

 

For Research Use Only. Not for use in diagnostic procedures.